Vivos Therapeutics Inc has a consensus price target of $6.25 based on the ratings of 2 analysts. The high is $10 issued by Roth Capital on August 13, 2021. The low is $2.5 issued by Ascendiant Capital on January 17, 2023. The 2 most-recent analyst ratings were released by Ascendiant Capital and Roth Capital on January 17, 2023 and August 13, 2021, respectively. With an average price target of $6.25 between Ascendiant Capital and Roth Capital, there's an implied 163.71% upside for Vivos Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
01/17/2023 | Buy Now | 5.49% | Ascendiant Capital | Edward Woo | → $62.5 | Initiates | → Buy | Get Alert |
08/13/2021 | Buy Now | 321.94% | Roth Capital | Scott Henry | $275 → $250 | Maintains | Buy | Get Alert |
The latest price target for Vivos Therapeutics (NASDAQ:VVOS) was reported by Ascendiant Capital on January 17, 2023. The analyst firm set a price target for $2.50 expecting VVOS to rise to within 12 months (a possible 5.49% upside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Vivos Therapeutics (NASDAQ:VVOS) was provided by Ascendiant Capital, and Vivos Therapeutics initiated their buy rating.
There is no last upgrade for Vivos Therapeutics
There is no last downgrade for Vivos Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vivos Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vivos Therapeutics was filed on January 17, 2023 so you should expect the next rating to be made available sometime around January 17, 2024.
While ratings are subjective and will change, the latest Vivos Therapeutics (VVOS) rating was a initiated with a price target of $0.00 to $2.50. The current price Vivos Therapeutics (VVOS) is trading at is $2.37, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.